List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 60 studies with search of:   "Myelofibrosis-osteosclerosis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting A Study in Myelofibrosis With Myeloid Metaplasia
Conditions: Myelofibrosis With Myeloid Metaplasia;   Myeloid Metaplasia;   Myelofibrosis
Intervention:
2 Active, not recruiting A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)
Conditions: Myelofibrosis;   Myeloid Metaplasia;   Agnogenic Myeloid Metaplasia;   Chronic Myelomonocytic Leukemia
Intervention: Drug: Imatinib mesylate
3 Completed PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP
Conditions: Acute Myelogenous Leukemia;   Agnogenic Myeloid Metaplasia;   Chronic Myelogenous Leukemia
Interventions: Drug: imatinib mesylate (Gleevec);   Drug: PTK 787 (vatalanib)
4 Active, not recruiting Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndromes;   Agnogenic Myeloid Metaplasia;   Myelofibrosis;   Hypereosinophilic Syndrome;   Polycythemia Vera;   Mastocytosis;   Leukemia, Myelomonocytic, Chronic
Intervention: Drug: Dasatinib (BMS-354825)
5 Recruiting A Prospective Multicentre Phase II Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)
Conditions: Myelofibrosis;   Myeloid Metaplasia
Intervention: Drug: zoledronic acid
6 Not yet recruiting A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Chronic Lymphocytic Leukemia;   Multiple Myeloma;   Waldenstrom's Macroglobulinemia;   Myelodysplastic Syndrome;   Philadelphia Chromosome-Negative CML;   Myeloid Metaplasia;   Myelofibrosis;   Advanced Polycythemia;   Non-Hodgkins Lymphoma
Intervention: Drug: TAK-901
7 Completed Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies
Conditions: Hematologic Malignancies;   Leukemia;   Myelodysplastic Syndromes;   Myeloid Metaplasia;   Lymphoma
Intervention: Drug: AP23573
8 Recruiting A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
Conditions: Hematological Malignancies;   Myelodysplasia;   Agnogenic Myeloid Metaplasia
Intervention: Drug: MKC-1
9 Recruiting Allogeneic Transplantation With Dose-Adjusted Busulfan
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma;   Myelodysplastic Syndromes;   Agnogenic Myeloid Metaplasia
Intervention: Drug: Busulfan
10 Active, not recruiting Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
Condition: Chronic Myeloproliferative Disorders
Intervention: Drug: tipifarnib
11 Active, not recruiting Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia
Conditions: Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders
Interventions: Drug: cyclophosphamide;   Drug: prednisone;   Drug: thalidomide;   Procedure: biopsy;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis
12 Active, not recruiting Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia
Condition: Myelofibrosis
Intervention: Drug: Obatoclax mesylate (GX15-070MS)
13 Completed RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
Conditions: Leukemia;   Mantle Cell Lymphoma;   Myelofibrosis
Intervention: Drug: RAD001
14 Completed Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Procedure: allogeneic bone marrow transplantation;   Procedure: radiation therapy
15 Active, not recruiting Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
Condition: Chronic Myeloproliferative Disorders
Interventions: Drug: lenalidomide;   Drug: prednisone
16 Active, not recruiting Imatinib Mesylate in Treating Patients With Myelofibrosis
Condition: Chronic Myeloproliferative Disorders
Intervention: Drug: imatinib mesylate
17 Completed Thalidomide in Treating Patients With Myelofibrosis
Condition: Chronic Myeloproliferative Disorders
Intervention: Drug: thalidomide
18 Active, not recruiting Allogeneic Stem Cell Transplantation (SCT) After Dose-Reduced Conditioning for Myelofibrosis Patients
Condition: Myelofibrosis
Intervention: Procedure: allogeneic HSCT
19 Active, not recruiting Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: methotrexate;   Drug: tacrolimus;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
20 Terminated In-Vivo Activated T-Cell Depletion to Prevent GVHD
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Chronic Lymphocytic Leukemia;   Myelodysplasia;   Lymphoma, Non-Hodgkin's;   Mantle-Cell Lymphoma;   Hodgkin's Disease;   Multiple Myeloma;   Myelofibrosis
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Cyclosporine;   Drug: Mycophenolate mofetil;   Drug: Basiliximab

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services